文献

J-GLOBAL ID：202102213862814807   整理番号：21A0574462

中国の薬局顧客における抗生物質および抗生物質耐性の知識,態度および実践:多施設調査研究【JST・京大機械翻訳】

Knowledge, Attitude, and Practices of Antibiotics and Antibiotic Resistance Among Chinese Pharmacy Customers: A Multicenter Survey Study

著者 (61件)： Li Pengchao (Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China) ,  Li Pengchao (Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710061, China) ,  Li Pengchao (Shaanxi Centre for Health Reform and Development Research, Xi’an 710061, China) ,  Li Pengchao (Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710061, China) ,  Hayat Khezar (Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China) ,  Hayat Khezar (Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710061, China) ,  Hayat Khezar (Shaanxi Centre for Health Reform and Development Research, Xi’an 710061, China) ,  Hayat Khezar (Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710061, China) ,  Hayat Khezar (Institute of Pharmaceutical Sciences, University of Veterinary and Animal Sciences, Lahore 54000, Pakistan) ,  Shi Li (Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China) ,  Shi Li (Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710061, China) ,  Shi Li (Shaanxi Centre for Health Reform and Development Research, Xi’an 710061, China) ,  Shi Li (Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710061, China) ,  Lambojon Krizzia (Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China) ,  Lambojon Krizzia (Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710061, China) ,  Lambojon Krizzia (Shaanxi Centre for Health Reform and Development Research, Xi’an 710061, China) ,  Lambojon Krizzia (Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710061, China) ,  Saeed Amna (Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China) ,  Saeed Amna (Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710061, China) ,  Saeed Amna (Shaanxi Centre for Health Reform and Development Research, Xi’an 710061, China) ,  Saeed Amna (Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710061, China) ,  Aziz Muhammad Majid (Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China) ,  Aziz Muhammad Majid (Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710061, China) ,  Aziz Muhammad Majid (Shaanxi Centre for Health Reform and Development Research, Xi’an 710061, China) ,  Aziz Muhammad Majid (Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710061, China) ,  Liu Tao (Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China) ,  Liu Tao (Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710061, China) ,  Liu Tao (Shaanxi Centre for Health Reform and Development Research, Xi’an 710061, China) ,  Liu Tao (Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710061, China) ,  Ji Shiyu (Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China) ,  Ji Shiyu (Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710061, China) ,  Ji Shiyu (Shaanxi Centre for Health Reform and Development Research, Xi’an 710061, China) ,  Ji Shiyu (Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710061, China) ,  Gong Yilin (Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China) ,  Gong Yilin (Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710061, China) ,  Gong Yilin (Shaanxi Centre for Health Reform and Development Research, Xi’an 710061, China) ,  Gong Yilin (Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710061, China) ,  Feng Zhitong (Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China) ,  Feng Zhitong (Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710061, China) ,  Feng Zhitong (Shaanxi Centre for Health Reform and Development Research, Xi’an 710061, China) ,  Feng Zhitong (Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710061, China) ,  Jiang Minghuan (Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China) ,  Jiang Minghuan (Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710061, China) ,  Jiang Minghuan (Shaanxi Centre for Health Reform and Development Research, Xi’an 710061, China) ,  Jiang Minghuan (Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710061, China) ,  Ji Wenjing (Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China) ,  Ji Wenjing (Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710061, China) ,  Ji Wenjing (Shaanxi Centre for Health Reform and Development Research, Xi’an 710061, China) ,  Ji Wenjing (Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710061, China) ,  Yang Caijun (Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China) ,  Yang Caijun (Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710061, China) ,  Yang Caijun (Shaanxi Centre for Health Reform and Development Research, Xi’an 710061, China) ,  Yang Caijun (Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710061, China) ,  Chang Jie (Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China) ,  Chang Jie (Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710061, China) ,  Chang Jie (Shaanxi Centre for Health Reform and Development Research, Xi’an 710061, China) ,  Chang Jie (Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710061, China) ,  Fang Yu (Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China) ,  Fang Yu (Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710061, China) ,  Fang Yu (Shaanxi Centre for Health Reform and Development Research, Xi’an 710061, China) ,  Fang Yu (Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710061, China)
資料名： Antibiotics (Web)  (Antibiotics (Web))
巻： 9  号： 4  ページ： 184  発行年： 2020年 
JST資料番号： U7132A  ISSN： 2079-6382  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： スイス (CHE)  言語： 英語 (EN)

抄録/ポイント： 背景:抗生物質に対する耐性は,主要な世界的な健康課題の1つである。合理的抗生物質使用に関する公衆の適切な理解は抗生物質耐性における進行を制限する必要条件である。本研究は,顧客訪問コミュニティ薬局間の抗生物質および抗生物質耐性の知識,態度および実践(KAP)を調べることを目的とした。方法:本研究は,28項目のアンケートを用いて,2019年3月2019年7月2019日,中国の3つの首都都市で行われた。アンケートは,社会人口統計学的特性,抗生物質に関するKAP,および抗生物質耐性を含む4つの部分を有した。系統的ランダムサンプリング法を用いて参加者を募集した。KruskalWallisとMann Whitneyテストをデータ解析のために実施した。結果:回答率は66.7%(1800/2700)であった。全体で,顧客の9.7%だけが抗生物質について良好な知識を有していた。参加者の約半分は抗生物質と抗炎症薬(n=820,45.6%,中央値=2,IQR=1)を区別することができなかった。大部分の顧客は,妊婦における対抗生物質の使用が安全でないという見解であった(n=1307,72.6%,中央値=2,IQR=0)。参加者のほとんど半分は,高価な抗生物質がより効果的で,副作用が少ない(n=897,49.9%,中央値=3,IQR=1)。参加者の22.3%だけが,彼らが抗生物質治療(n=401,22.3%,中央値=3,IQR=1)のコースを常に終えると言われていた。結論:中国の薬局消費者の知識は不十分であり,抗生物質使用の特定の側面における良好な態度と実践の欠如が観察された。抗生物質の公衆知識を増加させるには教育介入が必要である。Copyright 2021 The Author(s) All rights reserved. Translated from English into Japanese by JST.【JST・京大機械翻訳】

シソーラス用語： 教育 ,  消費者 ,  コミュニティ ,  都市 ,  消炎薬 ,  *抗生物質 ,  副作用 ,  *薬局 ,  データ解析 ,  アンケート ,  必要条件 ,  無作為抽出 ,  妊婦
準シソーラス用語： 人口統計学 ,  *微生物薬物耐性 , 【Automatic Indexing@JST】

著者キーワード (5件)： 抗生物質 ,  抗生物質耐性 ,  知識 ,  地域薬局 ,  中国

分類 (2件)： 公衆衛生  (GB02000X) ,  感染症・寄生虫症一般  (GD01010H)

引用文献 (42件)：

• O’NEILL, J. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. 2016. Available online: https://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf (accessed on 25 December 2019).
• Septimus, E.J. Antimicrobial Resistance: An Antimicrobial/Diagnostic Stewardship and Infection Prevention Approach. Med. Clin. North Am. 2018, 102, 819-829.
• Hayat, K.; Rosenthal, M.; Gillani, A.H.; Chang, J.; Ji, W.; Yang, C.; Jiang, M.; Zhao, M.; Fang, Y. Perspective of Key Healthcare Professionals on Antimicrobial Resistance and Stewardship Programs: A Multicenter Cross-Sectional Study From Pakistan. Front. Pharmacol. 2019, 10, 1520.
• Hayat, K.; Rosenthal, M.; Zhu, S.; Gillani, A.H.; Chang, J.; Bogale, A.A.; Kabba, J.A.; Yang, C.; Jiang, M.; Zhao, M. Attitude of clinicians towards hospital-based antimicrobial stewardship programs: A multicenter cross-sectional study from Punjab, Pakistan. Expert Rev. Anti Infect. Ther. 2019, 17, 661-669.
• Laxminarayan, R.; Duse, A.; Wattal, C.; Zaidi, A.K.; Wertheim, H.F.; Sumpradit, N.; Vlieghe, E.; Hara, G.L.; Gould, I.M.; Goossens, H.; et al. Antibiotic resistance-the need for global solutions. Lancet Infect. Dis. 2013, 13, 1057-1098.

タイトルに関連する用語 (9件)： 中国 ,  薬局 ,  顧客 ,  抗生物質 ,  抗生物質耐性 ,  知識 ,  態度 ,  多施設調査 ,  研究